137
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Circ_0060531 knockdown ameliorates IL-22-induced keratinocyte damage by binding to miR-330-5p to decrease GAB1 expression

, , , , &
Pages 243-253 | Received 10 Aug 2021, Accepted 30 Jan 2022, Published online: 16 Mar 2022

References

  • Boehncke WH, Schön MP. Psoriasis. Lancet. 2015;386(9997):983–994.
  • Liakou AI, Zouboulis CC. Links and risks associated with psoriasis and metabolic syndrome. Psoriasis (Auckl)). 2015;5:125–128.
  • Ritchlin CT, Colbert RA, Gladman DD. Psoriatic arthritis. N Engl J Med. 2017;376(10):957–970.
  • Roubille C, Richer V, Starnino T, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and Meta-analysis. Ann Rheum Dis. 2015;74(3):480–489.
  • Geller S, Xu H, Lebwohl M, et al. Malignancy risk and recurrence with psoriasis and its treatments: a concise update. Am J Clin Dermatol. 2018;19(3):363–375.
  • Chen LL. The biogenesis and emerging roles of circular RNAs. Nat Rev Mol Cell Biol. 2016;17(4):205–211.
  • Kristensen LS, Andersen MS, Stagsted LVW, et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20(11):675–691.
  • Li LJ, Zhu ZW, Zhao W, et al. Circular RNA expression profile and potential function of hsa_circ_0045272 in systemic lupus erythematosus. Immunology. 2018;155(1):137–149.
  • Iparraguirre L, Muñoz-Culla M, Prada-Luengo I, et al. Circular RNA profiling reveals that circular RNAs from ANXA2 can be used as new biomarkers for multiple sclerosis. Hum Mol Genet. 2017;26(18):3564–3572.
  • Zhou Z, Sun B, Huang S, et al. Roles of circular RNAs in immune regulation and autoimmune diseases. Cell Death Dis. 2019;10(7):503.
  • Wu X, Xiao Y, Ma J, et al. Circular RNA: a novel potential biomarker for skin diseases. Pharmacol Res. 2020;158:104841.
  • Qiao M, Ding J, Yan J, et al. Circular RNA expression profile and analysis of their potential function in psoriasis. Cell Physiol Biochem. 2018;50(1):15–27.
  • Essandoh K, Li Y, Huo J, et al. MiRNA-Mediated macrophage polarization and its potential role in the regulation of inflammatory response. Shock. 2016;46(2):122–131.
  • Bracken CP, Scott HS, Goodall GJ. A network-biology perspective of microRNA function and dysfunction in cancer. Nat Rev Genet. 2016;17(12):719–732.
  • Wu R, Zeng J, Yuan J, et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. J Clin Invest. 2018;128(6):2551–2568.
  • Suwanwongse K, Shabarek N. miRNA125b downregulation: a review of the novel paradigm of psoriasis epigenetic regulation. Cureus. 2020;12(1):e6798.
  • Elamir AM, Shaker OG, El-Komy MH, et al. The role of LncRNA MALAT-1 and MiRNA-9 in psoriasis. Biochem Biophys Rep. 2021;26:101030.
  • Chen J, Chen T, Zhu Y, et al. circPTN sponges miR-145-5p/miR-330-5p to promote proliferation and stemness in glioma. J Exp Clin Cancer Res. 2019;38(1):398.
  • Zuo W, Tian R, Chen Q, et al. miR-330-5p inhibits NLRP3 inflammasome-mediated myocardial ischaemia-reperfusion injury by targeting TIM3. Cardiovasc Drugs Ther. 2021;35(4):691–705.
  • Jin SL, Bai YM, Zhao BY, et al. Silencing of miR-330-5p stimulates osteogenesis in bone marrow mesenchymal stem cells and inhibits bone loss in osteoporosis by activating bgn-mediated BMP/smad pathway. Eur Rev Med Pharmacol Sci. 2020;24(8):4095–4102.
  • Liu Y, Rohrschneider LR. The gift of gab. FEBS Lett. 2002;515(1-3):1–7.
  • Chabot T, Cheraud Y, Fleury F. Relationships between DNA repair and RTK-mediated signaling pathways. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188495.
  • Sharma A, Menche J, Huang CC, et al. A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet. 2015;24(11):3005–3020.
  • Zhang YM, Zhang ZQ, Liu YY, et al. Requirement of Gαi1/3-Gab1 signaling complex for keratinocyte growth factor-induced PI3K-AKT-mTORC1 activation. J Invest Dermatol. 2015;135(1):181–191.
  • Di Cesare A, Di Meglio P, Nestle FO. The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol. 2009;129(6):1339–1350.
  • Wolk K, Witte E, Wallace E, et al. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur J Immunol. 2006;36(5):1309–1323.
  • Cai Y, Shen X, Ding C, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity. 2011;35(4):596–610.
  • Liu R, Chang W, Li J, et al. Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA. Exp Dermatol. 2019;28(3):292–299.
  • Lu J, Xu X, Li Y, et al. CircRAB3B suppresses proliferation, motility, cell cycle progression and promotes the apoptosis of IL-22-induced keratinocytes depending on the regulation of miR-1228-3p/PTEN axis in psoriasis. Autoimmunity. 2021;54(5):303–312.
  • Yang L, Zhang C, Bai X, et al. Hsa_circ_0003738 inhibits the suppressive function of tregs by targeting miR-562/IL-17A and miR-490-5p/IFN-γ signaling pathway. Mol Ther Nucleic Acids. 2020;21:1111–1119.
  • Zhang X, Yin M, Zhang L-J. Keratin 6, 16 and 17-Critical barrier alarmin molecules in skin wounds and psoriasis. Cells. 2019;8(8):807.
  • Li QJ, Chau J, Ebert PJ, et al. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell. 2007;129(1):147–161.
  • Li S, Zhu X, Zhang N, et al. LncRNA NORAD engages in psoriasis by binding to miR-26a to regulate keratinocyte proliferation. Autoimmunity. 2021;54(3):129–137.
  • Xue Y, Liu Y, Bian X, et al. miR-205-5p inhibits psoriasis-associated proliferation and angiogenesis: Wnt/β-catenin and mitogen-activated protein kinase signaling pathway are involved. J Dermatol. 2020;47(8):882–892.
  • Kim BK, Yoo HI, Choi K, et al. miR-330-5p inhibits proliferation and migration of keratinocytes by targeting Pdia3 expression. Febs J. 2015;282(24):4692–4702.
  • Zhou Y, Li X, Duan Y, et al. LncRNA MALAT-1 regulates the growth of interleukin-22-stimulated keratinocytes via the miR-330-5p/S100A7 axis. Autoimmunity. 2021;1–11.
  • Shen H, Zeng B, Wang C, et al. MiR-330 inhibits IL-22-induced keratinocyte proliferation through targeting CTNNB1. Biomed Pharmacother. 2017;91:803–811.
  • Luo M, Huang P, Pan Y, et al. Weighted gene coexpression network and experimental analyses identify lncRNA SPRR2C as a regulator of the IL-22-stimulated HaCaT cell phenotype through the miR-330/STAT1/S100A7 axis. Cell Death Dis. 2021;12(1):86.
  • Itoh M, Yoshida Y, Nishida K, et al. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol Cell Biol. 2000;20(10):3695–3704.
  • Kuwano Y, Fujimoto M, Watanabe R, et al. The involvement of Gab1 and PI 3-kinase in beta1 integrin signaling in keratinocytes. Biochem Biophys Res Commun. 2007;361(1):224–229.
  • Liu T, Zhang X, Wang Y. miR-183-3p suppresses proliferation and migration of keratinocyte in psoriasis by inhibiting GAB1. Hereditas. 2020;157(1):28.
  • He Q, Liu N, Hu F, et al. Circ_0061012 contributes to IL-22-induced proliferation, migration and invasion in keratinocytes through miR-194-5p/GAB1 axis in psoriasis. Bioscience Reports. 2021;41(1):BSR20203130.
  • Zhu X, Li Z, Pan W, et al. Participation of Gab1 and Gab2 in IL-22-mediated keratinocyte proliferation, migration, and differentiation. Mol Cell Biochem. 2012;369(1-2):255–266.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.